Stay updated on Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The record history now shows a new revision (v3.5.4) for the study record, reflecting an update to the page.
    Difference
    0.1%
    Check dated 2026-05-15T23:19:31.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page footer revision/version indicator was updated from v3.5.2 to v3.5.3, indicating a system release rather than a change to the displayed study record.
    Difference
    0.1%
    Check dated 2026-04-24T17:10:00.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2, replacing the previous v3.5.0 revision.
    Difference
    0.1%
    Check dated 2026-04-17T13:38:41.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed in the Record History to reflect the latest site release.
    Difference
    0.1%
    Check dated 2026-03-19T19:08:25.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added revision v3.4.3 to the record history, replacing v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T10:39:29.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T16:27:57.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.